(Q80854398)
Statements
Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan (English)
K Amarasinghe
C Dalley
I Dokal
A Laurie
scientific article published on 27 August 2007
No description defined